SynchroMed brings no pain relief for Medtronic
This article was originally published in Clinica
Executive Summary
Medtronic has agreed to the US FDA’s demands to stop making and distributing the SynchroMed II implantable infusion pumps, except in limited circumstances, until the company corrects quality system violations identified by the agency.